Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1999;33:1052-1056

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Frossard, P. M.
Right arrow Articles by Lestringant, G. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Frossard, P. M.
Right arrow Articles by Lestringant, G. G.
Right arrowPubmed/NCBI databases
*Genetics Home Reference
Medline Plus Health Information
*High Blood Pressure
Related Collections
Right arrow Clinical genetics
Right arrow Lipids
Right arrow Other hypertension

(Hypertension. 1999;33:1052-1056.)
© 1999 American Heart Association, Inc.


Scientific Contributions

Association of an Apolipoprotein B Gene Marker With Essential Hypertension

Philippe M. Frossard; Enyioma N. Obineche; Gilles G. Lestringant

From the Departments of Pathology (P.M.F.) and Internal Medicine (E.N.O.), Faculty of Medicine & Health Sciences, United Arab Emirates University, Al Ain; and the Department of Internal Medicine, Tawam Hospital (G.G.L.), Al Ain, United Arab Emirates.

Correspondence to Dr Philippe M. Frossard, Department of Pathology, Faculty of Medicine & Health Sciences, PO Box 17666, Al Ain, United Arab Emirates. E-mail frossard{at}emirates.net.ae

Abstract—We designed an association (retrospective, case control) study aimed at evaluating associations between genetic variations of the human apolipoprotein B (apoB) gene and clinical diagnosis of essential hypertension. Our approach was to compare the distribution of the alleles of a highly polymorphic variable number of tandem repeats localized 3' to the human apoB gene, the apoB 3' hypervariable region (HVR), in a group of normotensive and a group of hypertensive individuals. We collected DNA samples from 437 unrelated nationals (215 normotensives and 222 hypertensives) from the United Arab Emirates (UAEs), and we determined their apoB 3' HVR allele and genotype status with a polymerase chain reaction–based assay. In the UAE population, we found 18 alleles underlying a total of 51 genotypes. The distribution of these alleles was significantly different between normotensive and hypertensive UAE nationals. The main peak of the distributions occurred at 35 repeats among hypertensives (with a relative frequency of 25.7% versus 19.6% in normotensives) and at 37 repeats among normotensives (28.8% versus 20.3% in hypertensives). Alleles with 21, 23, 25, 49, and 55 repeats were found in hypertensives only (with a combined relative frequency of 7.6%). We conclude that variations of the apoB gene, or of a nearby gene, that may be in linkage disequilibrium with these alleles play a role in the development of essential hypertension in the UAEs.


Key Words: apolipoproteins B • case-control studies • genetics • hypertension, essential • repetitive sequences, nucleic acid • United Arab Emirates